Osteoporosis Drug Bazedoxifene Stops Growth Of Breast Cancer Cells
 

Bazedoxifene, an osteoporosis medication which is approved in Europe, stops the growth of breast cancer cells, including those that are resistant to current medications, researchers from the Duke Cancer Institute reported at ENDO 2013 - The Endocrine Society's Annual Meeting in San Francisco, California, June 15th, 2013...

More...